CaFite is simultaneously recruiting patients for a Phase I/II clinical trial for CF102 for treating HCV and liver cancer. <a href="http://www.globes.co.il/serveen/globes/DocView.asp?did=1000480599&fid=1725" rel="nofollow" target="_blank">http://www.globes.co.il/serveen/globes/DocView.asp?did=1000480599&fid=1725</a>